GGrantIndex
← Leaderboards

Ruanne Vanessa Barnabas

Massachusetts General Hospital

Google Scholar ↗PubMed ↗ORCID ↗
$3,934,321
Attributed
$15,723,984
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY2015–25
$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,648,604 · 9

By mechanism

U01$13,954,362 · 2
R01$3,004,631 · 2
R21$1,610,255 · 4
P30$79,356 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “South Africa”

Research focus

South AfricaCostBaseCommunitiesWomanCost EffectivenessHealth BenefitProviderCervicalEvaluationProgramsMortalityCollaborationsCancer ControlKenyaTransmission ProcessPoliciesCervical Cancer ScreeningPreventHiv SeropositivityComparativeCountryMalignant Neoplasm Of Cervix UteriPersons

Grant awards (35)

A sequential, adaptive model of differentiated service delivery to reach persons living with HIV who are lost-to-follow-up or who have detectable viral load$481,645
R01 · FY2025 · MH · contact PI
HIV and Malignancy Scientific Working Group$30,169
P30 · FY2025 · AI · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,171,441
U01 · FY2024 · CA
A sequential, adaptive model of differentiated service delivery to reach persons living with HIV who are lost-to-follow-up or who have detectable viral load$517,209
R01 · FY2024 · MH · contact PI
HIV and Malignancy Scientific Working Group$49,187
P30 · FY2024 · AI · contact PI
A sequential, adaptive model of differentiated service delivery to reach persons living with HIV who are lost-to-follow-up or who have detectable viral load$40,007
R01 · FY2024 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,225,767
U01 · FY2023 · CA
A sequential, adaptive model of differentiated service delivery to reach persons living with HIV who are lost-to-follow-up or who have detectable viral load$562,186
R01 · FY2023 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$375,112
U01 · FY2023 · CA
ConProject-001$80,011
R01 · FY2023 · MH · contact PI
A sequential, adaptive model of differentiated service delivery to reach persons living with HIV who are lost-to-follow-up or who have detectable viral load$80,011
R01 · FY2023 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,243,668
U01 · FY2022 · CA
A sequential, adaptive model of differentiated service delivery to reach persons living with HIV who are lost-to-follow-up or who have detectable viral load$558,742
R01 · FY2022 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies: METRICS PROSPR Supplement Phase 2$312,500
U01 · FY2022 · CA
Comparative Modeling to Inform Cervical Cancer Control Policies$42,462
U01 · FY2022 · CA
A sequential, adaptive model of differentiated service delivery to reach persons living with HIV who are lost-to-follow-up or who have detectable viral load$40,007
R01 · FY2022 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,290,361
U01 · FY2021 · CA
A sequential, adaptive model of differentiated service delivery to reach persons living with HIV who are lost-to-follow-up or who have detectable viral load$644,813
R01 · FY2021 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies - Moonshot Supplement$449,781
U01 · FY2021 · CA
Community tenofovir levels as a population adherence measure to understand the impact of oral PrEP on HIV acquisition among young women in sub-Saharan Africa$157,532
R21 · FY2021 · MH
Comparative Modeling to Inform Cervical Cancer Control Policies$75,750
U01 · FY2021 · CA
Comparative Modeling to Inform Cervical Cancer Control Policies$1,370,142
U01 · FY2020 · CA
Community tenofovir levels as a population adherence measure to understand the impact of oral PrEP on HIV acquisition among young women in sub-Saharan Africa$300,383
R21 · FY2020 · MH
Comparative Modeling to Inform Cervical Cancer Control Policies$1,183,281
U01 · FY2019 · CA
Comparative Modeling to Inform Cervical Cancer Control Policies$262,250
U01 · FY2019 · CA
Leveraging routing science to optimize ART delivery for efficient scale-up, high ART coverage, and viral suppression in South Africa$173,669
R21 · FY2019 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,222,591
U01 · FY2018 · CA
Leveraging routing science to optimize ART delivery for efficient scale-up, high ART coverage, and viral suppression in South Africa$217,096
R21 · FY2018 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,225,410
U01 · FY2017 · CA
Association between schistosomiasis and HIV-1 acquisition, transmission and disease progression in Africa$155,000
R21 · FY2017 · AI · contact PI
Do lottery incentive strategies increase engagement in HIV care and uptake of antiretroviral therapy among South African men?$146,625
R21 · FY2017 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,291,168
U01 · FY2016 · CA
Association between schistosomiasis and HIV-1 acquisition, transmission and disease progression in Africa$270,375
R21 · FY2016 · AI · contact PI
Do lottery incentive strategies increase engagement in HIV care and uptake of antiretroviral therapy among South African men?$189,575
R21 · FY2016 · MH · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,212,678
U01 · FY2015 · CA